Analysts and Recommendations
Sell side coverages: 18
Information contained on this website is updated on a regular basis. Due to the nature of some of the information posted, it becomes outdated rapidly. Please, be advised that information contained in this section of the website is not updated, and may not reflect the current situation of the Company.
| Buy/ Overperform/ Overweight/ Outperform |
16.67% |
Average (*) |
R$4.65 |
  |
| Neutral/ Hold/ In Line/ Marketperform/ Equal-weight |
61.11% |
Standard Deviation (*) |
R$0.78 | |
| Sell/ Underperform/ Underweight/ Market Underperform |
22.22% |
Higher (*) |
R$5.80 | |
| Under Review | – |
Lower (*) |
R$3.00 | |
| BROKER | ANALYST | TARGET PRICE (12 MONTHS) |
RECOMMENDATION |
|---|---|---|---|
| Autonomous | Craig Maurer | R$4.00 | Sell |
| Bank of America | Mario Pierry | R$5.80 | Hold |
| Bradesco BBI | Otavio Tanganelli | R$3.90 | Hold |
| Brasil Plural | Eduardo Nishio | R$5.30 | Buy |
| BTG Pactual | Eduardo Rosman | R$5.00 | Hold |
| Citi | Jörg Friedemann | R$5.50 | Hold |
| Credit Suisse | Daniel Federle | R$4.80 | Hold |
| Eleven | Carlos Daltozo | Under review | Buy |
| Goldman Sachs | Tito Labarta | R$3.40 | Sell |
| Guggenheim | Jeff Cantwell | N/A | Hold |
| HSBC | Neha Agarwala | R$5.00 | Buy |
| Itaú BBA | Marco Calvi | R$5.20 | Hold |
| JP Morgan | Domingos Falavina | N/A | Sell |
| Morgan Stanley | Jorge Kuri | R$4.50 | Hold |
| Safra | Luis Fernando F. Azevedo | R$5.00 | Hold |
| Santander | Henrique Navarro | R$3.00 | Sell |
| UBS BB | Mariana Taddeo | R$4.30 | Hold |
| XP Investimentos | Marcel Campos | R$5.00 | Hold |
Updated on February 24, 2021.
Cielo is covered by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Cielo´s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Company or its management. Cielo does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. The Company does not warrant that the above list of analysts is complete nor updated, and the information herein provided is subject to the authorization of the analysts.